Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Stress Resilience via BBB Integrity
NCT06965868Not yet recruiting
- Sponsor
- Leibniz Institute for Resilience Research
- Start
- Jun 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Randomised, double-blind trial comparing Metformin Arm with Placebo Arm (2 arms). Primary endpoint: Average Stressor Reactivity Score (Early Follow-up). Planned start Jun 2025; status: not yet recruiting.
02
Drugs
metformin
Beyond the preview
Go deeper on NCT06965868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06965868.